Eyepoint Goldman Sachs June 10 2025 · page 19 of 29
The chart compares DURAVYU 2.7mg, 1.3mg, and aflibercept 2mg. A red box highlights the early improvement at Week 4.
Consulting deck · case_study · illustrate_case · balanced density
Slide locked Sign in to view
Slide schematic 5/6
callout 1/1 chart 1/1 disclaimer 1/1 legend 1/1 metric 0/1 title 1/1
1 without position metric 1
metric · primary
Components 6
primary line disclaimer legend primary headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.